Author | Gerard Sanacora, MD, PhD

Articles

Rapid-Acting Antidepressants: Where Do We Stand with Ketamine?

September 05, 2014

Podcast

The lay press has focused a lot of attention on the use of ketamine as a potentially rapidly acting treatment for depression. But are psychiatrists really ready to offer ketamine as a treatment alternative for mood disorders? An expert weighs in.

Exploring New Therapeutic Areas in the Treatment of Depression and Bipolar Disorder

August 07, 2013

Article

Dr Gerard Sanacora discusses novel antidepressant agents with potential clinical relevance for the treatment of major depressive disorder and bipolar disorder.

Shedding Light on Glutamate for Mood Disorders

November 06, 2012

Podcast

New treatment options for mood disorders are under investigation, including the novel class of glutamatergic drugs.

New Medication Strategies for Non-responsive Depressed Patients

July 17, 2012

Podcast

A novel class of drugs directly targets the glutamatergic neurotransmitter system and produces rapid antidepressant effects in some patients.

Ketamine-Induced Optimism: New Hope for the Development of Rapid-Acting Antidepressants

July 13, 2012

Article

There is rapidly escalating interest in drugs that target the glutamatergic neurotransmitter system, especially NMDA receptor modulators. The hope is that they will fill the large unmet need for rapid-acting antidepressant medications with efficacy in treatment-resistant patients.